Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Antengene, Ardelyx, Ascletis, Astrazeneca, Beigene, Brexogen, Brim, Eccogene, Eisai, Kyowa Kirin, Moderna, Shanghai Henlius.